Post Title: Clinical Trial Liaison Officer (CTLO), HRB Clinical Research Coordination Ireland (HRB CRCI)
Post Status: Fixed Contract (Part-time 0.5 FTE)
Organisation: MMI Clinical Research Development Ireland CLG (CRDI)
Location: CRDI, 28 Mount St. Upper, Dublin 2, Ireland
Reports to: Chief Operations Officer HRB CRCI and HRB CRCI Chair
Salary: On request
Closing Date: Friday 1st February 2019 5.00 pm
Application Process: Curriculum Vitae and covering letter to email@example.com
HRB CRCI Background:
With the support of Health Research Board, Enterprise Ireland and Clinical Research Development Ireland (CRDI), the seven University-based Clinical Research Facilities/Centres (CRFs/Cs) in the Republic of Ireland have developed an integrated clinical trials network, the Health Research Board Clinical Research Co-ordination Ireland (HRB CRCI).
The aim of the HRB CRCI is to enhance Ireland’s capacity for conducting innovative high quality clinical research for the benefit of people’s health and the economy. Its mission is to advance healthcare by enabling a coordinated system with the specialist skills, expertise and infrastructure to design, conduct and analyse clinical trials and other intervention studies in Ireland, undertaken by networked clinician investigators and/or industry. It supports both academic and industry initiated clinical trials, involving pharmaceuticals, nutraceuticals and clinical care pathways as well as clinical investigation of medical devices.
The HRB CRCI now wishes to appoint a Clinical Trial Liaison Officer (CTLO) on a part-time basis (0.5) and on a fixed-term contract to May 2021, with the possibility of extension subject to funding. The HRB CRCI CTLO will deliver the HRB CRCI Clinical Trial Support Services as per the HRB CRCI’s 5-Year Business Plan, working in close collaboration with the HRB CRCI Clinical Trial Liaison Manager, HRB CRCI Chief Operations Officer (HRB CRCI COO), HRB CRCI Chair and HRB CRCI Team, both in the central office and at a local level.
The full job description can be viewed here.